Cure My Disease

Don't miss your cure!

 Log in / Sign up

New heart valve device tested in 25 patients

NCT ID NCT07601269

Recruiting now Disease control Sponsor: ReValve Solutions Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a new device called the ReValve system to replace the mitral valve in people with severe valve leakage. About 25 adults with symptoms like shortness of breath will get the device to see if it can be delivered safely and works as intended. The goal is to gather initial information on how well the system performs and its safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

mitral valve disorder mitral valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MITRAL VALVE REPLACEMENT

Contacts and locations

Locations

  • Institute Dante Pazzanese of Cardiology - IDPC

    RECRUITING

    São Paulo, São Paulo, SP, 04012-909, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Heart Institute - INCOR

    RECRUITING

    São Paulo, São Paulo, SP, 05403-900, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.